Table 2 Baseline characteristics of patients with cancer and healthy controls, including subgroups of patients with cancer.
Healthy (n = 128) | Leukemia (n = 10) | Solid tumor (n = 4) | Lymphoma (n = 5) | P | |
---|---|---|---|---|---|
Children Adolescents | 77 (60.2) 51 (39.8) | 5 (50) 5 (50) | 4 (100) — | 5 (100) | |
Gender: male | 65 (50.8) | 7 (70.0) | 1 (25.0) | 4 (80.0) | 0.23£ |
Age, mean (SD) | 10.7 (4.2) | 11.3 (4.7) | 9.6 (1.8) | 15.8 (1.6) | 0.058* |
Caries | 49 (38.3) | 4 (40.0) | 1 (25.0) | 0 (0.0) | 0.39£ |
Gingivitis | 35 (27.3) | 2 (20.0) | 1 (25.0) | 0 (0.0) | 0.72£ |
Washable plaque | 72 (56.2) | 5 (50.0) | 2 (50.0) | 2 (40.0) | 0.87£ |
Aphthae | 2 (1.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1£ |
Candidiasis | 1 (0.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1£ |
Hyposalivation | 0 (0.0) | 3 (30.0) | 0 (0.0) | 0 (0.0) | < 0.001£ |
Abnormal Mucosa | 6 (4.7) | 1 (10.0) | 1 (25.0) | 0 (0.0) | 0.16£ |
Salivary flow rate, mean (SD), ml/min | 1.04 (0.73) | 0.75 (0.45) | 0.78 (0.47) | 2.18 (1.17) | 0.003* |
IFN-γ, median (IQR), pg/ml | 1.1 (0.7, 2.7) | 3.1 (2.1, 6.2) | 4.0 (3.3, 4.8) | 0.9 (0.7, 1.5) | < 0.001# |
IL-1α, median (IQR), pg/ml | 756 (398, 1472) | 2065 (858, 2781) | 2187 (1594, 3492) | 847 (338, 1099) | 0.026# |
IL-1β, median (IQR), pg/ml | 16.1 (7.7, 36.6) | 80.3 (14.5, 267) | 78.7 (41.0, 134) | 7.4 (4.6, 10.2) | 0.008# |
IL-4, median (IQR), pg/ml | 1.4 (0.9, 2.0) | 2.1 (1.6, 2.8) | 2.1 (1.7, 2.3) | 1.5 (1.1, 1.6) | 0.16# |
IL-5, median (IQR), pg/ml | 0.9 (0.6, 1.3) | 1.7 (1.2, 2.5) | 2 (1.4, 2.7) | 0.7 (0.5, 0.7) | 0.005# |
IL-6, median (IQR), pg/ml | 2.9 (1.4, 8.1) | 4.5 (2.7, 10.9) | 3.3 (2.0, 41.4) | 3.0 (1.5, 3.7) | 0.42# |
IL-8, median (IQR), pg/ml | 282 (147, 609) | 805 (497, 1316) | 552 (156, 944) | 252 (161, 398) | 0.077# |
IL-10, median (IQR), pg/ml | 7.6 (4.3, 11.8) | 19.3 (12.1, 40.2) | 23.1 (18.4, 27.3) | 2.6 (2.6, 7.6) | < 0.001# |
IL-13, median (IQR), pg/ml | 9.0 (3.2, 18.9) | 14.6 (12.4, 19.6) | 22.7 (11.3, 32.8) | 7.3 (3.2, 9.0) | < 0.20# |
IP-10, median (IQR), pg/ml | 52.6 (17.7, 106) | 83.9 (26.0, 94.3) | 64.9 (22.4, 192) | 20.5 (11.6, 28.7) | 0.38# |
TNF, median (IQR), pg/ml | 7.7 (4.4, 13.1) | 12.8 (10.3, 21.0) | 20.7 (16.2, 26.6) | 6.7 (3.2, 12.5) | 0.006# |
VEGF-A, median (IQR), pg/ml | 164 (88.4, 256) | 200 (143, 362) | 214 (137, 333) | 111 (106, 295) | 0.50# |
pH, mean (SD) | n.a. | 7.9 (0.7) | 7.2 (1) | 8.1 (0.2) | n.c. |